Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunity, Cellular”

654 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 654 results

Not applicableStudy completedNCT04920162
What this trial is testing

Search for New Predictive Markers of the Immune Response in Vitiligo and Melanoma

Who this might be right for
Melanoma and Vitiligo
Centre Hospitalier Universitaire de Nice 10
Early research (Phase 1)Study completedNCT00117429
What this trial is testing

Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infections
Marcus Altfeld, M.D., Ph.D. 20
Large-scale testing (Phase 3)Study completedNCT00004984
What this trial is testing

The Diabetes Prevention Trial of Type 1 Diabetes (DPT-1)

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 711
Testing effectiveness (Phase 2)Study completedNCT03206073
What this trial is testing

A Phase I/II Study of Pexa-Vec Oncolytic Virus in Combination With Immune Checkpoint Inhibition in Refractory Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal CarcinomaColorectal Adenocarcinoma+2 more
National Cancer Institute (NCI) 34
Not applicableStudy completedNCT05713513
What this trial is testing

Manufacture of Clinical T-cell Products for Future Treatment

Who this might be right for
Virus-specific T Cells
University Hospital, Basel, Switzerland 9
Not applicableLooking for participantsNCT06944067
What this trial is testing

Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
National Human Genome Research Institute (NHGRI) 50
Early research (Phase 1)Study completedNCT00698100
What this trial is testing

Vaccination of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Human and Mouse Tyrosinase DNA Vaccines

Who this might be right for
MelanomaSkin
Memorial Sloan Kettering Cancer Center 18
Early research (Phase 1)Ended earlyNCT01216436
What this trial is testing

Local Modulation of Immune Receptors to Enhance the Response to Dendritic Cell Vaccination in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Duke University 2
Not applicableUnknownNCT04996927
What this trial is testing

18F-FDG PET/CT to Evaluate pD-1 Monoclonal Antibody With First-line Chemotherapy in Advanced NSCLC

Who this might be right for
NSCLC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 50
Not applicableStudy completedNCT02630537
What this trial is testing

Validation of Lophius Kits T-Track® CMV and T-Track® EBV in Hemodialysis Patients

Who this might be right for
Renal Failure Chronic Requiring Dialysis
Lophius Biosciences GmbH 133
Testing effectiveness (Phase 2)Study completedNCT00243594
What this trial is testing

Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection

Who this might be right for
Melanoma Stage III or IV
Radboud University Medical Center 40
Not applicableStudy completedNCT01558037
What this trial is testing

Cell Mediated Immunity With Risk of Cytomegalovirus (CMV) in Solid Organ Transplant Recipients

Who this might be right for
Awaiting Organ TransplantInfection in Solid Organ Transplant Recipients
Michael Ison 113
Testing effectiveness (Phase 2)UnknownNCT04725448
What this trial is testing

Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma

Who this might be right for
Pulmonary Sarcomatoid CarcinomaNon-small Cell Lung CancerLung Diseases+1 more
Sichuan Cancer Hospital and Research Institute 27
Not applicableEnded earlyNCT02439008
What this trial is testing

Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response

Who this might be right for
Carcinoma, HepatocellularColorectal NeoplasmsMelanoma+1 more
Centre Oscar Lambret 28
Not applicableStudy completedNCT00744159
What this trial is testing

Prospective Comparison of Immunological Benefit of Laparoscopic Colectomy

Who this might be right for
Immunity
Samsung Medical Center 84
Not applicableActive Not RecruitingNCT05708534
What this trial is testing

Evolution of CMV Antiviral T-cell Immunity Over the Next Six Months Initiation of Treatment With Belatacept.

Who this might be right for
Kidney Transplant Infection
University Hospital, Rouen 28
Early research (Phase 1)UnknownNCT00006209
What this trial is testing

Tucaresol in HIV-Infected Patients Who Are Taking Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Aaron Diamond AIDS Research Center 24
Not applicableLooking for participantsNCT04871932
What this trial is testing

COVID-2019 Vaccine Immune Response Base on Single Cell Multi-Omics

Who this might be right for
Immune System and Related Disorders
RenJi Hospital 50
Not applicableStudy completedNCT01730144
What this trial is testing

Studying Cell Immune Responses to a Live Flu Vaccine in Healthy Adults

Who this might be right for
Normal Physiology
National Institute of Allergy and Infectious Diseases (NIAID) 10
Large-scale testing (Phase 3)Active Not RecruitingNCT06449586
What this trial is testing

CMV-specific T Cell Immunity Test Indicated Prophylaxis of Letermovir After All-HSCT

Who this might be right for
Hematologic Malignancy
Ruijin Hospital 250
Next Page